Clinical Trials of an Innovative, First-in-Class Oral Therapy for the Treatment of a Broad Range of Women With HR+/HER2- Metastatic Breast Cancer
Loading Map....
Pfizer Cordially Invites You to Attend:
An Informational Program: Clinical Trials of an Innovative, First-in-Class Oral Therapy for the Treatment of a Broad Range of Women With HR+/HER2- Metastatic Breast Cancer
Featuring; JOHN PARK MD
University of California San Francisco
Hosted by Joyce Lew